VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PAVM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PAVMPAVmed Inc.
$5.25$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPAVMP/E History

PAVM logoPAVmed Inc. (PAVM) P/E Ratio History

Deep Value

Trading at -0.9x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2025–2025

Current P/E (TTM)
-0.9x
-3733% vs 5Y avg
5Y Avg P/E
0.0x
Median 0.0x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
-0.9x
Min0.0xMedian0.0xMax0.0x
TTM EPS$-443257.23
Price$5.25
Earnings YieldN/A
EPS Growth (1Y)-137.8%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of July 8, 2026, PAVmed Inc. (PAVM) trades at a price-to-earnings ratio of -0.9x, with a stock price of $5.25 and trailing twelve-month earnings per share of $-443257.23.

The current P/E is 3733% below its 5-year average of 0.0x. Over the past five years, PAVM's P/E has ranged from a low of 0.0x to a high of 0.0x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 23.4x, PAVM trades at a 104% discount to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 198.8x.

Relative to the broader market, PAVM trades at a notable discount to the S&P 500 median P/E of 25.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PAVM DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

PAVM Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-0.9vs23.4
-104%
Below Sector
vs. S&P 500
-0.9vs25.9
-104%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -138% EPS growth (1Y)

PAVM P/E vs Peers

Surgical tools, endoscopy, and robotics peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
INVA logoINVAInnoviva, Inc.
$2B6.7Lowest0.65Best+817%Best
TMDX logoTMDXTransMedics Group, Inc.
$2B14.6-+382%
MDT logoMDTMedtronic plc
$108B22.53.21+3%
BSX logoBSXBoston Scientific Corporation
$67B23.4-+55%
SYK logoSYKStryker Corporation
$120B37.32.51+8%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

PAVM Historical P/E Data (2025–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2025 Q2Jun 30 2025$0.60$34.740.0x-33%
FY2025 Q1Mar 31 2025$0.72$21.190.0x+33%

Average P/E for displayed period: 0.0x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

1+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PAVM — Frequently Asked Questions

Quick answers to the most common questions about buying PAVM stock.

What is PAVM's P/E ratio?

PAVmed Inc. (PAVM) trailing twelve-month P/E ratio is -0.9x, based on TTM diluted EPS of $-443257.23. The 5-year average P/E is 0.0x and the historical range spans 0.0x to 0.0x.

Is PAVM stock overvalued or undervalued?

PAVM current P/E: -0.9x. 5-year average P/E: 0.0x. Percentile: 0th.

Is PAVM stock expensive?

PAVM is fairly valued relative to its own history. The current P/E of -0.9x is near the 5-year average of 0.0x (0th percentile of historical range).

What is PAVM's historical P/E range?

Over the past 5 years, PAVM's P/E ratio has ranged from 0.0x to 0.0x, with a median of 0.0x and an average of 0.0x. The current P/E of -0.9x places the stock at the 0th percentile of this range. Full historical data spans 2025–2025.

How does PAVM's P/E compare to the S&P 500?

PAVM trades at -0.9x P/E versus the S&P 500 median of 25.9x. The 103% discount to the market suggests lower growth expectations or perceived higher risk.

How does PAVM's valuation compare to Healthcare peers?

PAVmed Inc. P/E of -0.9x compares to the Healthcare sector median of 23.4x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is PAVM's PEG ratio?

PAVM PEG ratio is N/A, based on a P/E of -0.9x and EPS growth of -137.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is PAVM's earnings yield?

PAVM earnings yield is N/A, the inverse of its -0.9x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

PAVM P/E Ratio History (2025–2025)

Quarterly valuation multiple from closing price and trailing EPS

Current0.0x
Period Avg0.0x
Range0.0x - 0.0x
Change-49%
2 quartersMar 31, 2025 - Jun 30, 2025